Pharmaceutical Intermediates: Sourcing 2-(Phenylthio)ethyl Acrylate (CAS 95175-38-5)
The pharmaceutical industry relies heavily on a consistent supply of high-purity chemical intermediates to ensure the efficacy and safety of finished drug products. Among these crucial components is 2-(Phenylthio)ethyl Acrylate (CAS 95175-38-5), a versatile fine chemical that plays a significant role in various synthesis pathways. For R&D scientists and procurement managers in the pharmaceutical sector, understanding the utility and sourcing of this intermediate is vital for efficient drug development and manufacturing.
The Role of 2-(Phenylthio)ethyl Acrylate in Pharmaceuticals
2-(Phenylthio)ethyl Acrylate, identified by CAS 95175-38-5, is a chemical compound with the molecular formula C11H12 O2 S. Its structure and reactive nature make it a valuable building block in the synthesis of more complex pharmaceutical molecules. As a pharmaceutical intermediate, its consistent quality, characterized by a typical purity of 98%, is non-negotiable. The physical properties, such as its appearance as a white powder, density of 1.12 g/cm³, and a high boiling point, are standard specifications that ensure predictability in chemical reactions. Pharmaceutical companies often require detailed analytical data, including Mass Spectrometry and NMR, to validate the identity and purity of such intermediates.
Strategic Sourcing from China Manufacturers
When seeking to buy 2-(Phenylthio)ethyl Acrylate for pharmaceutical applications, sourcing from experienced manufacturers in China offers a compelling proposition. Chinese chemical suppliers have developed robust quality control systems and adhere to international manufacturing standards, making them reliable partners for the global pharmaceutical supply chain. For procurement teams, finding a competitive cas 95175-38-5 price is a key objective. Engaging with reputable companies that specialize in fine chemical intermediates ensures that you not only get cost-effective solutions but also products that meet stringent quality requirements. A thorough vetting process, including review of certifications like ISO, and requesting sample batches for in-house testing, is highly recommended.
Ensuring Supply Chain Stability
A stable and reliable supply chain is critical for pharmaceutical production. Partnering with a well-established supplier of 2-(Phenylthio)ethyl Acrylate from China can mitigate risks associated with material shortages or quality inconsistencies. These suppliers often have significant production capacities and a proven track record in global logistics. By establishing a direct relationship, pharmaceutical companies can gain better insights into production schedules and anticipate potential supply fluctuations. This proactive approach is essential for uninterrupted drug manufacturing and timely delivery to market. When sourcing, always ask about lead times and minimum order quantities to align with your production planning.
Conclusion: Quality Intermediate for Innovation
2-(Phenylthio)ethyl Acrylate is more than just a chemical; it is a critical link in the chain of pharmaceutical innovation. By strategically sourcing this intermediate from reliable China-based manufacturers and suppliers, pharmaceutical companies can ensure the quality and cost-effectiveness necessary for successful drug development and production. Always prioritize suppliers who demonstrate a strong commitment to quality assurance and transparent communication to foster a resilient and productive partnership.
Perspectives & Insights
Quantum Pioneer 24
“12 g/cm³, and a high boiling point, are standard specifications that ensure predictability in chemical reactions.”
Bio Explorer X
“Pharmaceutical companies often require detailed analytical data, including Mass Spectrometry and NMR, to validate the identity and purity of such intermediates.”
Nano Catalyst AI
“Strategic Sourcing from China Manufacturers When seeking to buy 2-(Phenylthio)ethyl Acrylate for pharmaceutical applications, sourcing from experienced manufacturers in China offers a compelling proposition.”